Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE3
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
- Status
- UNKNOWN
- Phase
- PHASE3
Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of G-CSF-Priming in Elderly AML Patients
- Status
- UNKNOWN
- Phase
- PHASE4
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
- Status
- COMPLETED
- Phase
- PHASE4
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
- Status
- COMPLETED
- Phase
- PHASE4
Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplant for Immunologic or Histiocytic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2